| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |